1. Home
  2. QNST vs IOVA Comparison

QNST vs IOVA Comparison

Compare QNST & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuinStreet Inc.

QNST

QuinStreet Inc.

N/A

Current Price

$12.16

Market Cap

870.0M

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$4.03

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QNST
IOVA
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.0M
2.1B
IPO Year
2009
2008

Fundamental Metrics

Financial Performance
Metric
QNST
IOVA
Price
$12.16
$4.03
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$24.75
$9.11
AVG Volume (30 Days)
828.8K
15.8M
Earning Date
05-07-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
0.94
N/A
Revenue
$282,140,000.00
N/A
Revenue This Year
$18.59
$49.14
Revenue Next Year
$14.96
$51.69
P/E Ratio
$12.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.29
$1.64
52 Week High
$19.53
$5.63

Technical Indicators

Market Signals
Indicator
QNST
IOVA
Relative Strength Index (RSI) 51.57 54.58
Support Level $10.79 $1.99
Resistance Level $12.62 $4.34
Average True Range (ATR) 0.46 0.48
MACD 0.16 0.06
Stochastic Oscillator 75.41 42.91

Price Performance

Historical Comparison
QNST
IOVA

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: